An Israeli study found that the 4th COVID booster shot is ineffective in preventing the disease.
This is horrible news for the Medical Industrial Complex.
Via James Cintolo.
A study out of Sheba Medical Center in Israel has proven that a 4th dose of either Pfizer or Moderna is ineffective against Omicron. Preliminary data was released on Monday 1/17/22 showing high antibody titers but low protection. Here’s an examination of the data, and 3 lessons we can learn from this.
To start, 274 healthcare workers at Sheba Medical Center received a 4th dose. Specifically, 154 received Pfizer, and 120 received Moderna. They were compared with a control group of nearly 6,000 healthcare workers that didn’t receive a booster. Prof. Gili Regev-Yochay, lead researcher commented, “We see an increase in antibodies, higher than after the third dose,” he stated. “However, we see many infected with Omicron who received the fourth dose”. T elaborate, around the same number of individuals that received 4 doses experienced as many breakthrough infections as those who received 3. That said, there are a few lessons to learn from this.
This may explain the crash in vaccine stocks Moderna and BioTech.
Alex Berenson reported:
The hedge funds have finally realized there will be no fourth shot. And that mRNA technology, erm, still has a few issues to work out. (1 billion people aren’t gonna love hearing that, but too late now. Mistakes were made, stuff happens, amirite?)
Moderna and BioNTech are down 8-10% today, 60% since August. Oh, how I wish I could have shorted them.
The post Israel Study Finds 4th Booster Shot Ineffective — Moderna and Biotech Stocks Are Cratering appeared first on The Gateway Pundit.
